Glucagon Administration by Nasal and Intramuscular Routes in Adults With Type 1 Diabetes During Insulin-Induced Hypoglycaemia: A Randomised, Open-Label, Crossover Study.

Suico, Jeffrey G; Hövelmann, Ulrike; Zhang, Shuyu; Shen, Tong; Bergman, Brandon; Sherr, Jennifer; Zijlstra, Eric; Frier, Brian M; Plum-Mörschel, Leona

Suico, Jeffrey G; Hövelmann, Ulrike; Zhang, Shuyu; Shen, Tong; Bergman, Brandon; Sherr, Jennifer; Zijlstra, Eric; Frier, Brian M; Plum-Mörschel, Leona.

Afiliación

Suico JG; Eli Lilly and Company, Indianapolis, IN, USA. suico_jeffrey_gideon@lilly.com.
Hövelmann U; Profil, Neuss, Germany.
Zhang S; Eli Lilly and Company, Indianapolis, IN, USA.
Shen T; Eli Lilly and Company, Indianapolis, IN, USA.
Bergman B; Eli Lilly and Company, Indianapolis, IN, USA.
Sherr J; Endocrinology, Department of Pediatrics (Endocrinology), Yale School of Medicine, New Haven, CT, USA.
Zijlstra E; Profil, Neuss, Germany.
Frier BM; The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
Plum-Mörschel L; Profil, Mainz, Germany.

Diabetes Ther ; 11(7): 1591-1603, 2020 Jul.

Article en En | MEDLINE | ID: mdl-32514794

Palabras clave

Insulin-induced hypoglycaemia; Intramuscular glucagon; Nasal glucagon; Type 1 diabetes

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Diabetes Ther Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google